Global Peptide Therapeutics Market Professional Survey Report 2017

October 2017 | 107 pages | ID: GA82D518286PEN
QYResearch

Abstracts

This report studies Peptide Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Eli Lilly and Company
• Bachem Holding
• Amgen
• Roche
• GlaxoSmithKline
• Novartis
• Sanofi
• Takeda Pharmaceutical Company
• Teva Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• by Phase
• Liquid Phase
• Solid Phase
• Hybrid Phase
• by Type of Molecule
• Vasopressin
• Somatostatin
• Calcitonin
• Immunopeptide
• Natriuretic
• Others

By Application, the market can be split into

• Hospitals Pharmacies
• Retail Pharmacies
• Drug Stores
• E-Commerce

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Peptide Therapeutics Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PEPTIDE THERAPEUTICS

1.1 Definition and Specifications of Peptide Therapeutics
  1.1.1 Definition of Peptide Therapeutics
  1.1.2 Specifications of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics
  1.2.1 Liquid Phase
  1.2.2 Solid Phase
  1.2.3 Hybrid Phase
1.3 Applications of Peptide Therapeutics
  1.3.1 Hospitals Pharmacies
  1.3.2 Retail Pharmacies
  1.3.3 Drug Stores
  1.3.4 E-Commerce
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PEPTIDE THERAPEUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Peptide Therapeutics
2.3 Manufacturing Process Analysis of Peptide Therapeutics
2.4 Industry Chain Structure of Peptide Therapeutics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PEPTIDE THERAPEUTICS

3.1 Capacity and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2016

4 GLOBAL PEPTIDE THERAPEUTICS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Peptide Therapeutics Capacity and Growth Rate Analysis
  4.2.2 2016 Peptide Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Peptide Therapeutics Sales and Growth Rate Analysis
  4.3.2 2016 Peptide Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Peptide Therapeutics Sales Price
  4.4.2 2016 Peptide Therapeutics Sales Price Analysis (Company Segment)

5 PEPTIDE THERAPEUTICS REGIONAL MARKET ANALYSIS

5.1 North America Peptide Therapeutics Market Analysis
  5.1.1 North America Peptide Therapeutics Market Overview
  5.1.2 North America 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Peptide Therapeutics Sales Price Analysis
  5.1.4 North America 2016 Peptide Therapeutics Market Share Analysis
5.2 China Peptide Therapeutics Market Analysis
  5.2.1 China Peptide Therapeutics Market Overview
  5.2.2 China 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Peptide Therapeutics Sales Price Analysis
  5.2.4 China 2016 Peptide Therapeutics Market Share Analysis
5.3 Europe Peptide Therapeutics Market Analysis
  5.3.1 Europe Peptide Therapeutics Market Overview
  5.3.2 Europe 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Peptide Therapeutics Sales Price Analysis
  5.3.4 Europe 2016 Peptide Therapeutics Market Share Analysis
5.4 Southeast Asia Peptide Therapeutics Market Analysis
  5.4.1 Southeast Asia Peptide Therapeutics Market Overview
  5.4.2 Southeast Asia 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Peptide Therapeutics Sales Price Analysis
  5.4.4 Southeast Asia 2016 Peptide Therapeutics Market Share Analysis
5.5 Japan Peptide Therapeutics Market Analysis
  5.5.1 Japan Peptide Therapeutics Market Overview
  5.5.2 Japan 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Peptide Therapeutics Sales Price Analysis
  5.5.4 Japan 2016 Peptide Therapeutics Market Share Analysis
5.6 India Peptide Therapeutics Market Analysis
  5.6.1 India Peptide Therapeutics Market Overview
  5.6.2 India 2012-2017E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Peptide Therapeutics Sales Price Analysis
  5.6.4 India 2016 Peptide Therapeutics Market Share Analysis

6 GLOBAL 2012-2017E PEPTIDE THERAPEUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Peptide Therapeutics Sales by Type
6.2 Different Types of Peptide Therapeutics Product Interview Price Analysis
6.3 Different Types of Peptide Therapeutics Product Driving Factors Analysis
  6.3.1 by Phase of Peptide Therapeutics Growth Driving Factor Analysis
  6.3.2 by Type of Molecule of Peptide Therapeutics Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PEPTIDE THERAPEUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Peptide Therapeutics Consumption by Application
7.2 Different Application of Peptide Therapeutics Product Interview Price Analysis
7.3 Different Application of Peptide Therapeutics Product Driving Factors Analysis
  7.3.1 Hospitals Pharmacies of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.2 Retail Pharmacies of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.3 Drug Stores of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.4 E-Commerce of Peptide Therapeutics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PEPTIDE THERAPEUTICS

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 Peptide Therapeutics Business Region Distribution Analysis
8.2 Eli Lilly and Company
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Eli Lilly and Company 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Eli Lilly and Company 2016 Peptide Therapeutics Business Region Distribution Analysis
8.3 Bachem Holding
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Bachem Holding 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Bachem Holding 2016 Peptide Therapeutics Business Region Distribution Analysis
8.4 Amgen
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Amgen 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Amgen 2016 Peptide Therapeutics Business Region Distribution Analysis
8.5 Roche
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Roche 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Roche 2016 Peptide Therapeutics Business Region Distribution Analysis
8.6 GlaxoSmithKline
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 GlaxoSmithKline 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 GlaxoSmithKline 2016 Peptide Therapeutics Business Region Distribution Analysis
8.7 Novartis
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Novartis 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novartis 2016 Peptide Therapeutics Business Region Distribution Analysis
8.8 Sanofi
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Sanofi 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Sanofi 2016 Peptide Therapeutics Business Region Distribution Analysis
8.9 Takeda Pharmaceutical Company
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Takeda Pharmaceutical Company 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Takeda Pharmaceutical Company 2016 Peptide Therapeutics Business Region Distribution Analysis
8.10 Teva Pharmaceutical
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Teva Pharmaceutical 2016 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Teva Pharmaceutical 2016 Peptide Therapeutics Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF PEPTIDE THERAPEUTICS MARKET

9.1 Global Peptide Therapeutics Market Trend Analysis
  9.1.1 Global 2017-2022 Peptide Therapeutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Peptide Therapeutics Sales Price Forecast
9.2 Peptide Therapeutics Regional Market Trend
  9.2.1 North America 2017-2022 Peptide Therapeutics Consumption Forecast
  9.2.2 China 2017-2022 Peptide Therapeutics Consumption Forecast
  9.2.3 Europe 2017-2022 Peptide Therapeutics Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Peptide Therapeutics Consumption Forecast
  9.2.5 Japan 2017-2022 Peptide Therapeutics Consumption Forecast
  9.2.6 India 2017-2022 Peptide Therapeutics Consumption Forecast
9.3 Peptide Therapeutics Market Trend (Product Type)
9.4 Peptide Therapeutics Market Trend (Application)

10 PEPTIDE THERAPEUTICS MARKETING TYPE ANALYSIS

10.1 Peptide Therapeutics Regional Marketing Type Analysis
10.2 Peptide Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Peptide Therapeutics by Region
10.4 Peptide Therapeutics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PEPTIDE THERAPEUTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PEPTIDE THERAPEUTICS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Peptide Therapeutics
Table Product Specifications of Peptide Therapeutics
Table Classification of Peptide Therapeutics
Figure Global Production Market Share of Peptide Therapeutics by Type in 2016
Figure Liquid Phase Picture
Table Major Manufacturers of Liquid Phase
Figure Solid Phase Picture
Table Major Manufacturers of Solid Phase
Figure Hybrid Phase Picture
Table Major Manufacturers of Hybrid Phase
Table Applications of Peptide Therapeutics
Figure Global Consumption Volume Market Share of Peptide Therapeutics by Application in 2016
Figure Hospitals Pharmacies Examples
Table Major Consumers in Hospitals Pharmacies
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Drug Stores Examples
Table Major Consumers in Drug Stores
Figure E-Commerce Examples
Table Major Consumers in E-Commerce
Figure Market Share of Peptide Therapeutics by Regions
Figure North America Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure China Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Peptide Therapeutics Market Size (Million USD) (2012-2022)
Figure India Peptide Therapeutics Market Size (Million USD) (2012-2022)
Table Peptide Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Peptide Therapeutics in 2016
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Industry Chain Structure of Peptide Therapeutics
Table Capacity and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Peptide Therapeutics 2012-2017
Figure Global 2012-2017E Peptide Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Peptide Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Peptide Therapeutics Capacity and Growth Rate
Table 2016 Global Peptide Therapeutics Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Peptide Therapeutics Sales (K Units) and Growth Rate
Table 2016 Global Peptide Therapeutics Sales (K Units) List (Company Segment)
Table 2012-2017E Global Peptide Therapeutics Sales Price (USD/Unit)
Table 2016 Global Peptide Therapeutics Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure North America 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure North America 2016 Peptide Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure China 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure China 2016 Peptide Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Europe 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Europe 2016 Peptide Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Southeast Asia 2016 Peptide Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure Japan 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure Japan 2016 Peptide Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Peptide Therapeutics 2012-2017E
Figure India 2012-2017E Peptide Therapeutics Sales Price (USD/Unit)
Figure India 2016 Peptide Therapeutics Sales Market Share
Table Global 2012-2017E Peptide Therapeutics Sales (K Units) by Type
Table Different Types Peptide Therapeutics Product Interview Price
Table Global 2012-2017E Peptide Therapeutics Sales (K Units) by Application
Table Different Application Peptide Therapeutics Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Peptide Therapeutics Business Region Distribution
Table Eli Lilly and Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly and Company Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly and Company Peptide Therapeutics Business Region Distribution
Table Bachem Holding Information List
Table Product A Overview
Table Product B Overview
Table 2015 Bachem Holding Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bachem Holding Peptide Therapeutics Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Peptide Therapeutics Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Peptide Therapeutics Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Peptide Therapeutics Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Peptide Therapeutics Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Peptide Therapeutics Business Region Distribution
Table Takeda Pharmaceutical Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Pharmaceutical Company Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Takeda Pharmaceutical Company Peptide Therapeutics Business Region Distribution
Table Teva Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Peptide Therapeutics Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Peptide Therapeutics Business Region Distribution
Figure Global 2017-2022 Peptide Therapeutics Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Peptide Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Peptide Therapeutics Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Peptide Therapeutics Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Peptide Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Units) of Peptide Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Peptide Therapeutics by Region